Creafund Mergers and Acquisitions Summary

Growth Capital Firm Profile

In the last 3 years, Creafund has acquired 3 companies. It has also invested in 2 others.

Creafund’s most common sectors for investment areconsumer products (20%) and life science (20%) . The Firm’s most common investment types include growth capital (30%) and buyout (lbo, mbo, mbi) (20%). In total, Creafund has invested in 2 different countries. Its largest (disclosed) acquisition occurred in 2020 when it acquired Vision Healthcare N.V. for $344M.

The Firm’s most common exit type is trade sale (100%).

Join Mergr to view Creafund’s full profile and discover more small growth capital firm investors just like it.

M&A Summary

  • M&A Total Activity11
    • M&A Buy Activity10
    • M&A Sell Activity1
  • Total Sectors Invested 7
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 2

Creafund

Kapitein Maenhoutstraat 77 B,
Sint-Martens-Latem, 9830
Belgium
+32 9 272 62 00
www.creafund.be
assistant@creafund.be

Creafund is a private holding company that looks to acquire majority stakes in mature Belgian companies. Creafund takes majority stakes of between €5 and €25m in Belgian SMEs, being companies with EBITDA of between €2.5m and €25m, alongside entrepreneurs, family shareholders, and management. Prospective transaction situations include growth capital financings, buyouts, and consolidations. Creafund was formed in 2001 and is based in Sint-Martens-Latem, Belgium.


Investment Criteria

Sectors of Interest: Building Materials, Business Services, Construction, Consumer Products, Life Science, Manufacturing, Packaging, Semiconductors, Transportation

Target Transaction Types: Buyout (LBO, MBO, MBI), Consolidation, Divestiture, Growth Capital, Secondary Buyout, Stake Purchase

Geographic Preferences: Western Europe

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA 3 25
Investment Size 5 25
Enterprise Value 20 100
values in millions of EUR

M&A Summary

Buy vs Sell

Year ≤ '18 '19 '20 '21 '22 '23 T
Buy (1.0/yr) # 5 - 1 3 1 - 10
vol $344M $344M
Sell (0.2/yr) # - 1 - - - - 1
  11

Most Recent M&A

Company Date Value Type
Coeman Packaging 2022-06-03 - Growth Capital
Waregem, Belgium · www.coeman.be
Sitra Group 2021-12-06 - Stake Purchase
Ypres, Belgium · www.sitra-group.com
Sofics 2021-09-01 - Recapitalization
Aalter, Belgium · www.sofics.com
Cooper Consumer Health SAS 2021-03-12 - Secondary Buyout
Paris, France · www.cooperconsumerhealth.eu
Vision Healthcare N.V. 2020-06-01 344M EUR Divestiture
Kortrijk, Belgium · www.visionhealthcare.eu
Mylène nv 2019-01-04 - Add-on Acquisition
Heist-op-den-Berg, Belgium · www.mylene.eu
Diresco NV 2018-01-01 - Buyout (LBO, MBO, MBI)
Oudsbergen, Belgium · www.diresco.be
Mylène nv 2015-10-15 - Buyout (LBO, MBO, MBI)
Heist-op-den-Berg, Belgium · www.mylene.eu
TFF Group 2015-01-01 - Stake Purchase
Saint Romain , France · www.tff-group.com
Beddeleem NV 2014-01-01 - Growth Capital
Groot-Bijgaarden, Belgium · www.beddeleem.be
View All >>

Portfolio M&A

Company Acquired Add-On/Sale Date #
Vision Healthcare N.V. 2020-06-01 NaturaMed Pharma AS 2020-12-21 4
Kortrijk, Belgium · www.visionhealthcare.eu Drammen, Netherlands · www.naturamed-pharma.no

M&A by Sector

Sector Current # Value All-time # Value
Consumer Products 1 (11%) 344M (100%) 2 (20%) 344M (100%)
Life Science 2 (22%) - 2 (20%) -
Packaging 2 (22%) - 2 (20%) -
Building Materials 1 (11%) - 1 (10%) -
Construction 1 (11%) - 1 (10%) -
Semiconductors 1 (11%) - 1 (10%) -
Transportation 1 (11%) - 1 (10%) -
Total 9 $344M 10 $344M

Acquisitions By Geo

State/Country Current # Value All-time # Value
Belgium 7 (78%) 344M (100%) 8 (80%) 344M (100%)
France 2 (22%) - 2 (20%) -
Total 9 $344M 10 $344M

Acquisitions by Deal Type

Type Current # Value All-time # Value
Growth Capital 3 (33%) - 3 (30%) -
Buyout (LBO, MBO, MBI) 1 (11%) - 2 (20%) -
Stake Purchase 2 (22%) - 2 (20%) -
Divestiture 1 (11%) 344M (100%) 1 (10%) 344M (100%)
Recapitalization 1 (11%) - 1 (10%) -
Secondary Buyout 1 (11%) - 1 (10%) -
Total 9 $344M 10 $344M

Exits by Deal Type

Type Total # Value
Trade Sale 1 (100%) -
Total 1 -

Deal Values

buy # Total
$100M to $1B 1 $344M
TOTAL $344M
Largest Vision Healthcare N.V.
$344M (2020-06-01)

M&A Connections

Deals
Acquired from
Investor(s)
10%
1 (10%)
Strategic(s)
10%
1 (10%)
Exited to
Strategic(s)
100%
1 (100%)

Investor Summary

Investor Type

Growth Capital Firm

Size

Small

PE Assets

100M EUR

Established

2001

Specialist/Generalist

Generalist

Leadership

Herman Wielfaert

CEO

Gino Schepens

Managing Director

Kenneth Depuydt

Investment Director

Ruth De Wulf

Investment Director

 Subscribe to unlock this and 189,272
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.4K Private Equity Firms
  • 180K M&A Transactions
  • 185K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.5K M&A Advisors
    (Investment Banks and Law Firms)
  • 68K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal